RIGHTS ISSUE

Home
Company
About us
Management
Board of Directors
Scientific Advisory Board
Partnerships

Partnerships
Nox Science
NOX Enzymes

NADPH Oxidase
NOX Enzyme Family
NOX Expression

NOX and Disease

Oxidative Stress and Disease
Physiological Functions of NOX
Fibrotic diseases
Neurodegenerative diseases
Cardiovascular diseases

Publications
Pipeline
Setanaxib
Preclinical NOX1 program
Research programs
Investors
Stock information
Analyst coverage
Contribution project

Press release
Project presentation
Documentation
Shareholders general meeting

Press releases

2020
2019
2018
2017
2016
2015
2014

Events and presentations
Regulated information

Financial information

2020
2019
2018
2017
2016
2015
2014

Other regulated information

2020
2019
2018
2017
2016
2015
2014

Governance
OCABSA warrants

Shareholder information

Shareholders’ meetings

2020
2019

AGM of June 13, 2019
AGE of January 2019

2018

AGM of june 13, 2018

2017

AGM of June 15, 2017
AGM of February 28, 2017

2016
2015
2014

Agenda
News and Events
Press releases
Events and presentations
Media

Press clippings
Interviews
Contacts
RIGHTS ISSUE

Investors /
Regulated information /
Financial information /
2020

Financial information

There are no articles in this category. If subcategories display on this page, they may have articles.

Stock information
Analyst coverage
Contribution project
Press releases
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Events and presentations
Regulated information
Shareholder information
- Shareholders’ meetings
- Agenda

Ask us your questions

Suscribe to Newsletter

Legal terms

© 2020 genkyotex.com